Deep Dive Into Immunocore Hldgs Stock: Analyst Perspectives (9 Ratings)
Deep Dive Into Immunocore Hldgs Stock: Analyst Perspectives (9 Ratings)
深入探討Immunocore Hldgs股票：分析師觀點（9個評級）
Ratings for Immunocore Hldgs (NASDAQ:IMCR) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去的三個月中，有9位分析師對Immunocore Hldgs (NASDAQ:IMCR) 進行了評級，展示了看好和看淡兩種不同的觀點。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近評級的精簡視圖，顯示了過去30天的不同情緒，並將其與前幾個月進行比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $86.44, a high estimate of $100.00, and a low estimate of $66.00. This current average represents a 0.77% decrease from the previous average price target of $87.11.
分析師通過評估12個月的價格目標來提供更深入的見解，揭示了平均目標價爲86.44美元，高估價爲100.00美元，低估價爲66.00美元。該目前的平均價值代表了較前一個平均目標價87.11美元的0.77%的下降。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級：全面解析
The analysis of recent analyst actions sheds...
近期分析師對 ...
登入免費觀看全文
登入/註冊